We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
-8.89%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.51B
AUM Growth
-$307M
Cap. Flow
+$14.9M
Cap. Flow %
0.6%
Top 10 Hldgs %
23.56%
Holding
327
New
15
Increased
111
Reduced
164
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Healthcare 23.72%
3 Industrials 14.58%
4 Consumer Discretionary 12.89%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WNS
1
DELISTED
WNS Holdings
WNS
$78.2M 3.11%
914,305
-14,358
-2% -$1.23M
EEFT icon
2
Euronet Worldwide
EEFT
$2.77B
$64.8M 2.58%
498,073
-9,038
-2% -$1.15M
ACIW icon
3
ACI Worldwide
ACIW
$5.81B
$64M 2.55%
2,031,893
-14,285
-0.7% -$477K
ZD icon
4
Ziff Davis
ZD
$1.92B
$63.7M 2.54%
658,373
-11,678
-2% -$1.2M
DOOR
5
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$60M 2.39%
675,132
-7,133
-1% -$705K
LRN icon
6
Stride
LRN
$3.48B
$56.9M 2.27%
1,565,713
-7,348
-0.5% -$244K
MED icon
7
Medifast
MED
$108M
$55.7M 2.22%
326,039
-693
-0.2% -$131K
SMTC icon
8
Semtech
SMTC
$11.1B
$54.2M 2.16%
781,845
-14,101
-2% -$1.01M
WWE
9
DELISTED
World Wrestling Entertainment
WWE
$47.9M 1.91%
767,630
+46,351
+6% +$2.56M
DFIN icon
10
Donnelley Financial Solutions
DFIN
$1.21B
$45.9M 1.83%
1,379,133
-3,015
-0.2% -$108K
SIMO icon
11
Silicon Motion
SIMO
$8.86B
$43.8M 1.74%
655,099
-20,392
-3% -$1.59M
PINC
12
DELISTED
Premier
PINC
$42.3M 1.69%
1,188,647
-21,206
-2% -$789K
PBH icon
13
Prestige Consumer Healthcare
PBH
$2.35B
$40.7M 1.62%
768,697
-10,802
-1% -$624K
AX icon
14
Axos Financial
AX
$5.69B
$39.9M 1.59%
859,130
-25,575
-3% -$1.35M
RDWR icon
15
Radware
RDWR
$1.07B
$39M 1.56%
1,221,070
-5,508
-0.4% -$183K
LGND icon
16
Ligand Pharmaceuticals
LGND
$5.84B
$38.8M 1.55%
552,985
-4,376
-0.8% -$317K
LCII icon
17
LCI Industries
LCII
$2.46B
$36.7M 1.46%
353,070
-6,065
-2% -$759K
PCRX icon
18
Pacira BioSciences
PCRX
$1.04B
$34.9M 1.39%
456,798
+36,593
+9% +$2.44M
BHVN
19
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$32.8M 1.31%
277,006
-4,945
-2% -$617K
AWI icon
20
Armstrong World Industries
AWI
$7.31B
$32.6M 1.3%
361,882
-6,528
-2% -$632K
NGVT icon
21
Ingevity
NGVT
$2.48B
$31.3M 1.25%
487,846
-43,811
-8% -$2.93M
POOL icon
22
Pool Corp
POOL
$6.77B
$31.2M 1.24%
73,880
-1,588
-2% -$742K
RXT icon
23
Rackspace Technology
RXT
$1.06B
$30.5M 1.21%
2,731,145
+222,187
+9% +$2.63M
MEDP icon
24
Medpace
MEDP
$16B
$30M 1.2%
183,556
+19,884
+12% +$3.28M
MTN icon
25
Vail Resorts
MTN
$5.39B
$28.2M 1.12%
108,276
-1,973
-2% -$537K

Similar funds

Rice Hall James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Rice Hall James & Associates held 327 positions worth $2.51B, down 11% from $2.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q1 2022 filing shows 15 new, 111 increased, 164 reduced and 21 closed positions. Its largest new stake was Digital Turbine: 491,443 shares worth $21.5M. The largest sale was Mimecast Limited, an estimated $15.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q1 2022 buy was Digital Turbine: 491,443 shares worth $21.5M.
  • Rice Hall James & Associates added most to Neurocrine Biosciences in Q1 2022, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q1 2022 reduction was Mimecast Limited, cutting an estimated $15.9M.
  • Rice Hall James & Associates fully exited Zogenix, Inc. in Q1 2022, selling an estimated $12.6M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.51B portfolio in Q1 2022.
  • Rice Hall James & Associates opened 15 new positions and closed 21 in Q1 2022.
  • Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $2.51B.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.